Abstract
Full list of author information is available at the end of the articleIntroduction Osteoarthritis (OA) is the most common arthritis, char-acterized by progressive loss of articular cartilage, sub-chondral bone remodeling, and synovial inflammation, leading to debilitating joint pain and functional limita-tion [1,2]. The underlying pathophysiologic process of cartilage destruction in OA has not been completely elucidated. Inflammation is believed to be implicated in the OA pathogenesis, even in early stages, by shifting the balance from the anabolic toward the catabolic state with gradually progressive cartilage loss. In OA, chon-drocytes, the only cells residing in cartilage, are a target of catabolic cytokines, including interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and IL-6. IL-1β in par-ticular has been considered a key amplifier and perpetu-ator of cartilage damage because it suppresses matrix protein synthesis and induces matrix-degrading enzymes and other proinflammatory cytokines, including IL-6 [3,4].